Home » Topics » BioWorld Science

BioWorld Science
RSS

Prodrugs of thrombin inhibitors prepared at BMS

Nov. 18, 1997

Searle reports inhibitors of iNOS

Nov. 18, 1997

New MMP inhibitors from Pharmacia & Upjohn

Nov. 18, 1997

New ECE inhibitors patented by Roussel Uclaf

Nov. 18, 1997

New antidepressant and cognition enhancer developed in Russia

Nov. 17, 1997

Biomira and Intracel negotiate acquisition of certain Biomira assets

Nov. 17, 1997

Amylin Pharmaceuticals: Q3 1997 highlights

Nov. 17, 1997

Celecoxib: safety and efficacy data presented at rheumatology meeting

Nov. 17, 1997

Novartis submits BLA for Simulect in U.S.

Nov. 17, 1997

Cardioprotective activity of monoHER demonstrated in preclinical models

Nov. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...